Fecal microbiota transplantation may improve immunotherapy-related colitis
Immunotherapy-related colitis is a potentially serious side effect of immunotherapy that can force patients to pause cancer treatment?
The majority of patients in this study saw improvements in colitis after receiving fecal microbiota transplantation (FMT)
Colitis symptoms improved within a median of 1.5 days after treatment?
Targeting the gut microbiome with fecal microbiota transplantation (FMT) may help cancer patients...
Most patients with appendix cancer may avoid chemotherapy after surgery, study suggests
Researchers found fewer than 10% of patients experienced cancer recurrence after surgery
Chemotherapy after surgery was not associated with...
Blood test could monitor bone metastasis in medullary thyroid cancer
Medullary thyroid cancer often spreads to the bone in advanced disease, causing abnormal bone growth
Researchers discovered the OPG protein...
Targeted antibody improves outcomes for patients with advanced lung cancer who have faced treatment resistance
Phase 3 HARMONi study evaluated ivonescimab plus chemotherapy for patients with EGFR-mutant lung cancer whose tumors stopped responding to treatment
This combination cut the risk of cancer progression nearly in half compared to chemotherapy alone
Patients on ivonescimab-chemotherapy treatment lived more than two months longer without their cancer worsening
HOUSTON, SEPTEMBER 4, 2026 ¡ª Patients with EGFR-mutant...
Psilocybin prevents chemotherapy-related nerve injury and associated symptoms in preclinical models
Peripheral neuropathy is a common side effect of chemotherapy treatment, resulting in symptoms that can include numbness, painful nerve injury...
Daraxonrasib demonstrates initial antitumor activity in RAS-mutant lung cancer
Daraxonrasib is a RAS inhibitor from Revolution Medicines that has been approved by the Food & Drug Administration for previously treated...